Most patients with HBeAg-negative chronic hepatitis B have an elevated risk of cirrhosis and liver cancer, and serum Chi3l1 can act as a diagnostic marker and risk factor for liver fibrosis in these patients [84]. The gene discussed is CHI3L1; the disease is Hepatic fibrosis.